Improving Food and Drug Administration–Centers for Medicare and Medicaid Services Coordination for Drugs Granted Accelerated Approval
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Improving Food and Drug Administration–Centers for Medicare and Medicaid Services Coordination for Drugs Granted Accelerated Approval
Authors
Keywords
-
Journal
MILBANK QUARTERLY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2023-08-30
DOI
10.1111/1468-0009.12670
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Association Between Preapproval Confirmatory Trial Initiation and Conversion to Traditional Approval or Withdrawal in the FDA Accelerated Approval Pathway
- (2023) Mahnum Shahzad et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Unwanted Advice? Frequency, Characteristics, And Outcomes Of Negative Advisory Committee Votes For FDA-Approved Drugs
- (2022) C. Joseph Ross Daval et al. HEALTH AFFAIRS
- Designing Cures 2.0 — From Corridors to Cornerstones
- (2022) Kushal T. Kadakia et al. NEW ENGLAND JOURNAL OF MEDICINE
- Real-World Evidence — Where Are We Now?
- (2022) John Concato et al. NEW ENGLAND JOURNAL OF MEDICINE
- Use of Extrapolation in New Drug Approvals by the US Food and Drug Administration
- (2022) Daniel Feldman et al. JAMA Network Open
- Accelerated Approval — Taking the FDA’s Concerns Seriously
- (2022) Rachel E. Sachs et al. NEW ENGLAND JOURNAL OF MEDICINE
- Medical Device User Fee Reauthorization — Back to Basics or Looking Ahead?
- (2022) Vinay K. Rathi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Improving the Use of FDA Advisory Committees
- (2022) C. Joseph Ross Daval et al. NEW ENGLAND JOURNAL OF MEDICINE
- Medicare’s National Coverage Determination for Aducanumab — A One-Off or a Pragmatic Path Forward?
- (2022) Sanket S. Dhruva et al. NEW ENGLAND JOURNAL OF MEDICINE
- The On- and Off-Ramps of Oncology Accelerated Approval
- (2022) Lola A. Fashoyin-Aje et al. NEW ENGLAND JOURNAL OF MEDICINE
- HARmonized Protocol Template to Enhance Reproducibility of hypothesis evaluating real‐world evidence studies on treatment effects: A good practices report of a joint ISPE/ISPOR task force
- (2022) Shirley V. Wang et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- The FDA Struggle to Withdraw Makena
- (2022) Daniel G. Aaron et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Preapproval Promises to Voluntarily Withdraw FDA-Approved Drugs
- (2022) Holly Fernandez Lynch et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- “Dangling” Accelerated Approvals in Oncology
- (2021) Julia A. Beaver et al. NEW ENGLAND JOURNAL OF MEDICINE
- Revisiting FDA Approval of Aducanumab
- (2021) G. Caleb Alexander et al. NEW ENGLAND JOURNAL OF MEDICINE
- Use of Real-World Evidence for Regulatory Approval and Coverage of Medical Devices: A Landscape Assessment
- (2021) Justin W. Timbie et al. VALUE IN HEALTH
- Regulatory and clinical consequences of negative confirmatory trials of accelerated approval cancer drugs: retrospective observational study
- (2021) Bishal Gyawali et al. BMJ-British Medical Journal
- Feasibility of Using Real-world Data to Emulate Postapproval Confirmatory Clinical Trials of Therapeutic Agents Granted US Food and Drug Administration Accelerated Approval
- (2021) Joshua D. Wallach et al. JAMA Network Open
- FDA Approval and Regulation of Pharmaceuticals, 1983-2018
- (2020) Jonathan J. Darrow et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The Magic of Randomization versus the Myth of Real-World Evidence
- (2020) Rory Collins et al. NEW ENGLAND JOURNAL OF MEDICINE
- Harmonizing Standards and Incentives in Medical Device Regulation: Lessons Learned from the Parallel Review Pathway
- (2019) Jessica N. Holtzman et al. JOURNAL OF LAW MEDICINE & ETHICS
- Use of Health Care Databases to Support Supplemental Indications of Approved Medications
- (2018) Michael Fralick et al. JAMA Internal Medicine
- Coverage of Novel Therapeutic Agents by Medicare Prescription Drug Plans Following FDA Approval
- (2018) Daniel L. Shaw et al. Journal of Managed Care & Specialty Pharmacy
- Characteristics of Preapproval and Postapproval Studies for Drugs Granted Accelerated Approval by the US Food and Drug Administration
- (2017) Huseyin Naci et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Speed, Safety, and Industry Funding — From PDUFA I to PDUFA VI
- (2017) Jonathan J. Darrow et al. NEW ENGLAND JOURNAL OF MEDICINE
- Conflicts of Interest for Patient-Advocacy Organizations
- (2017) Matthew S. McCoy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Good Practices for Real‐World Data Studies of Treatment and/or Comparative Effectiveness: Recommendations from the Joint ISPOR‐ISPE Special Task Force on Real‐World Evidence in Health Care Decision Making
- (2017) Marc L. Berger et al. VALUE IN HEALTH
- Patient Advocacy Organizations, Industry Funding, and Conflicts of Interest
- (2017) Susannah L. Rose et al. JAMA Internal Medicine
- Accelerated Drug Approval and Health Inequality
- (2016) Alex John London et al. JAMA Internal Medicine
- CHANGING FACE OF MEDICARE’S NATIONAL COVERAGE DETERMINATIONS FOR TECHNOLOGY
- (2015) James D. Chambers et al. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE
- Medicare's Enduring Struggle to Define “Reasonable and Necessary” Care
- (2012) Peter J. Neumann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Medicare and Medical Technology — The Growing Demand for Relevant Outcomes
- (2010) Peter J. Neumann et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started